Financial Performance - The company's revenue for Q1 2022 was CNY 252,430,407.65, representing a 0.64% increase compared to CNY 250,824,651.33 in the same period last year[2] - Net profit attributable to shareholders decreased by 19.54% to CNY 16,732,432.89 from CNY 20,796,366.59 year-on-year[2] - Basic and diluted earnings per share decreased by 39.29% to CNY 0.17 from CNY 0.28 in the same period last year[2] - Total operating revenue for Q1 2022 was CNY 252,430,407.65, a slight increase of 0.24% compared to CNY 250,824,651.33 in Q1 2021[22] - Net profit for Q1 2022 was CNY 16,732,432.89, a decrease of 19.9% compared to CNY 20,796,366.59 in Q1 2021[24] Cash Flow - The net cash flow from operating activities fell by 33.30% to CNY 14,440,830.58, down from CNY 21,649,804.23 in the previous year[9] - The net cash flow from operating activities for Q1 2022 was ¥14,440,830.58, a decrease from ¥21,649,804.23 in Q1 2021, reflecting a decline of approximately 33.5%[28] - The company experienced a 101.62% decline in net cash flow from financing activities, dropping to CNY -5,928,124.54 from CNY 365,367,685.87 in the previous year[9] - The total cash outflow from investment activities was ¥68,505,128.76, significantly higher than ¥30,659,491.17 in the previous year, indicating an increase of about 123.5%[28] - The cash inflow from investment activities was ¥35,561,986.31, with no cash inflow reported in the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,320,889,214.74, a decrease of 2.72% from CNY 1,357,869,202.64 at the end of the previous year[2] - Total liabilities decreased to CNY 347,091,051.91 from CNY 400,796,781.00 year-over-year[21] - As of March 31, 2022, total current assets amounted to RMB 674,746,200.53, down from RMB 737,615,637.22 at the beginning of the year, representing a decrease of approximately 8.5%[19] - Cash and cash equivalents decreased from RMB 166,841,784.23 at the beginning of the year to RMB 142,276,797.24, a decline of about 14.7%[19] - Accounts receivable decreased from RMB 285,696,819.68 to RMB 260,030,236.01, reflecting a reduction of approximately 9.0%[19] Equity and Shareholder Information - The total equity attributable to shareholders increased by 1.75% to CNY 973,798,162.83 from CNY 957,072,421.64 at the end of the previous year[2] - The company plans to lift restrictions on 55,938,212 shares held by major shareholder Zeng Bensheng in March 2024[14] - The company’s total number of shareholders with restricted shares was 75,600,000 at the beginning of the period, with 19,661,788 shares released during the reporting period[15] Operational Costs and Expenses - Total operating costs for Q1 2022 were CNY 234,373,717.17, up 2.99% from CNY 227,560,049.93 in the previous year[22] - Research and development expenses for Q1 2022 were CNY 4,907,138.69, slightly up from CNY 4,804,988.62 in Q1 2021[22] - Other income decreased by 60.78% to CNY 263,311.74, primarily due to a reduction in government subsidies received[7] Miscellaneous - The company did not conduct an audit for the Q1 2022 report[29] - The company has disclosed all major matters as required by the Securities Law and the Management Measures for Information Disclosure of Listed Companies[16]

Financial Performance - The company reported a profit distribution plan of 3.80 RMB per 10 shares (including tax) for a total of 100,800,000 shares[5]. - The company's operating revenue for 2021 was CNY 1,161,295,192.74, representing a 19.89% increase compared to CNY 968,606,344.36 in 2020[20]. - The net profit attributable to shareholders for 2021 was CNY 97,169,266.47, a 4.02% increase from CNY 93,411,508.52 in 2020[20]. - The net cash flow from operating activities increased by 32.39% to CNY 99,936,853.58 in 2021, compared to CNY 75,484,674.92 in 2020[20]. - The total assets at the end of 2021 reached CNY 1,357,869,202.64, a 55.38% increase from CNY 873,929,046.40 at the end of 2020[20]. - The net assets attributable to shareholders increased by 80.99% to CNY 957,072,421.64 at the end of 2021, compared to CNY 528,800,062.08 at the end of 2020[20]. - The basic earnings per share decreased by 16.94% to CNY 1.03 in 2021, down from CNY 1.24 in 2020[20]. - The company reported a total of CNY 2,892,855.39 in non-recurring gains and losses for 2021, compared to CNY 2,667,075.14 in 2020[25]. - The company achieved a total asset of CNY 1.358 billion as of December 31, 2021, representing a growth of 55.38% compared to the previous year[73]. - The net assets attributable to shareholders of the listed company reached CNY 957 million, an increase of 80.99% year-on-year[73]. - The company reported an operating revenue of CNY 1.161 billion for 2021, marking a year-on-year growth of 19.89%[73]. - The net profit attributable to shareholders of the listed company was CNY 97.17 million, reflecting a growth of 4.02% compared to the previous year[73]. - The net cash flow from operating activities was CNY 99.94 million, which is a 32.39% increase year-on-year[73]. Market Trends and Opportunities - The cosmetics market in China saw a retail sales increase from CNY 204.94 billion in 2015 to CNY 402.6 billion in 2021, with a growth rate of 14% in 2021[30]. - The company is positioned to benefit from the growing demand for personalized and differentiated products in the cosmetics OEM/ODM sector[30]. - The company has experienced a significant increase in its market opportunities due to the rising consumer income levels and the ongoing trend of consumption upgrades in the cosmetics industry[30]. - The collaboration between brand owners and manufacturers is deepening, with stable OEM/ODM partnerships becoming essential for product innovation and capacity expansion, aiding brand growth[31]. - The demand for cosmetics OEM/ODM services is increasing due to the stable growth of the Chinese cosmetics market, with local brands focusing on localized operations and e-commerce channels[32]. - The cosmetics industry in China is experiencing a growth phase, with significant opportunities for OEM/ODM enterprises as brand outsourcing needs diversify[33]. - The cosmetics production industry is characterized by low cyclicality and strong resilience to economic fluctuations, with production concentrated in the Yangtze River Delta and Pearl River Delta regions[38]. - The company is actively investing in R&D for lightweight plastics, recycling, and biodegradable plastic applications to address environmental concerns[64]. - The company is developing innovative personal care products and anti-aging products, aiming to enhance market competitiveness[91]. Risks and Challenges - The company emphasizes potential risks including market demand fluctuations, high customer concentration, and raw material price volatility[5]. - The top five customers accounted for 76.64% of total annual sales, with the largest customer contributing 30.92%[88]. - The company faces risks from rising raw material prices, particularly for PE and PP, which are heavily influenced by international crude oil prices, potentially impacting profit margins[136]. - The company has identified risks related to the feasibility of fundraising investment projects, which may not meet expected returns due to market changes[139]. - The company is facing risks from rising raw material prices, particularly for PE and PP, which are heavily influenced by international crude oil prices, potentially impacting profit margins[136]. - The company reported a significant inventory amount of 171.10 million yuan, accounting for 23.20% of current assets, which may lead to operational risks due to high capital occupation[138]. Corporate Governance - The company maintains complete independence from its controlling shareholder in terms of business, assets, personnel, and finance, ensuring a fully autonomous operational capability[150]. - The board of directors consists of 7 members, including 3 independent directors, all of whom comply with legal and regulatory requirements[147]. - The company has established a complete and independent business system, with no reliance on controlling shareholders for procurement, sales, design, or technology[150]. - The company has a fully independent financial department and accounting system, with no interference from the controlling shareholder in financial decisions[151]. - The company has established a transparent information disclosure system, ensuring all shareholders receive equal access to relevant information[148]. - The company has engaged in multiple research projects, enhancing its product development capabilities in the cosmetics sector[162]. - The company has not faced any penalties from securities regulatory authorities in the past three years for its current and recently departed directors, supervisors, and senior management[161]. - The company has not engaged in any related party transactions that would compromise its independence or operational integrity[152]. Research and Development - The company has established a comprehensive R&D system and a stable, efficient, and experienced technical R&D team to support product development[66]. - The company is collaborating with research institutions like Fudan University to advance its R&D capabilities in cosmetic technologies[75]. - The company has accumulated 163 domestic patents and 1 foreign patent, including 32 invention patents, 98 utility model patents, and 34 design patents[61]. - The company has invested RMB 21.95 million in R&D, representing an 18.48% increase compared to the previous year, and obtained 14 patents during the reporting period[75]. - The company is committed to increasing R&D investment to keep pace with customer demands for product updates and to avoid being outpaced by competitors[137]. Production and Operations - The company primarily engages in the OEM/ODM of daily chemical products and the design and production of plastic packaging containers, providing integrated services for cosmetics and household care products[41]. - The production model is mainly order-based, with a focus on OEM services while also providing ODM services for certain brand clients[53]. - The sales model involves direct sales and efficient supply chain management to quickly meet customer delivery needs, with pricing based on a cost-plus method[54]. - The company has a design capacity of 24,500 tons for cosmetics, with a utilization rate of 98%, and a design capacity of 87 million units for plastic packaging containers, with a utilization rate of 77%[61]. - The company has formed a synergistic strategy between its OEM/ODM business for daily chemical products and its plastic packaging business, leading to rapid growth in the daily chemical sector[55]. - The company has a clean production workshop with a 100,000-level standard, ensuring stable production capacity and quality control[69]. - The company is enhancing its smart manufacturing capabilities through the construction of digital management systems, including PLM, MES, and WMS[76]. Shareholder Engagement - The company held its annual general meeting with a participation rate of 75% on May 20, 2021, and two interim shareholder meetings with participation rates of 64.26% and 67.54% on July 15, 2021, and November 22, 2021, respectively[153]. - The company has ensured that minority shareholders had sufficient opportunities to express their opinions and protect their legal rights[180]. - The company has not provided guarantees for the controlling shareholder or its affiliates during the reporting period, nor has it allowed any fund occupation by the controlling shareholder[150]. - The company responded to 136 investor inquiries through the "Interactive Easy" platform and held one online performance briefing during the reporting period[193]. Environmental and Social Responsibility - The company has maintained compliance with environmental laws and regulations, achieving ISO 14001 certification for its main subsidiaries[194]. - The company has committed to sustainable development by focusing on energy conservation, emission reduction, and technological upgrades in its operations[194]. - The company has established a dedicated pandemic prevention task force and organized COVID-19 vaccination for employees in response to government directives[194]. - The company emphasizes quality over profit in its product philosophy, ensuring high-quality products and services for customers[192].

嘉亨家化股份有限公司 2021 年第三季度报告 证券代码：300955 证券简称：嘉亨家化 公告编号：2021-055 嘉亨家化股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中 财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 317,638,952.46 | 15.66% | 831,891,115.67 | 24.76% | | ...

Financial Performance - The company reported a revenue of RMB 1.2 billion for the first half of 2021, representing a year-on-year increase of 15% compared to RMB 1.04 billion in the same period of 2020[16]. - The company's operating revenue for the reporting period was ¥514,252,163.21, representing a 31.13% increase compared to ¥392,171,139.30 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was ¥37,192,009.57, a decrease of 6.72% from ¥39,870,921.68 in the previous year[23]. - The net cash flow from operating activities increased significantly by 480.76%, reaching ¥49,841,012.94 compared to ¥8,582,068.97 in the previous year[23]. - The total comprehensive income for the first half of 2021 was ¥18,813,127.78, compared to ¥13,684,651.88 in the same period of 2020, representing an increase of approximately 37.1%[191]. Cost and Profitability - The gross profit margin improved to 45% in the first half of 2021, up from 42% in the previous year, indicating better cost management and pricing strategies[16]. - The company's operating expenses increased by 10% to RMB 300 million, primarily due to increased marketing efforts and logistics costs[16]. - The gross margin for cosmetics decreased by 6.72% to 21.61%, while the gross margin for plastic packaging containers decreased by 1.13% to 24.85%[67]. Research and Development - The company has allocated RMB 50 million for research and development in new technologies and product formulations for 2021, aiming to enhance product efficacy and sustainability[16]. - Research and development investment increased by 30.35% to ¥10,576,850.17, focusing on cosmetics formulation, new materials, and performance research[62]. - The company is actively investing in formula R&D and production process optimization in the cosmetics field[30]. Market Expansion and Strategy - The company plans to expand its product line with the introduction of three new skincare products by the end of 2021, targeting a market share increase of 5% in the skincare segment[16]. - Market expansion efforts include entering two new provinces in China, projected to contribute an additional RMB 100 million in revenue by the end of 2022[16]. - The company is exploring potential acquisition opportunities in the personal care sector to enhance its market position and product offerings[16]. Customer and Supplier Relationships - User data indicates a 20% increase in active customers, reaching 2 million by June 30, 2021, compared to 1.67 million in the same period last year[16]. - The company has established long-term relationships with suppliers to ensure a stable supply of raw materials and effective cost control[38]. - The company has established long-term partnerships with major clients such as Johnson & Johnson and YuMeiJing, demonstrating strong quality control and production capabilities[51]. Regulatory and Risk Management - The company faces risks including fluctuations in raw material prices and potential impacts from the COVID-19 pandemic, which are detailed in the risk management section of the report[4]. - The company is subject to various regulatory frameworks, including the "Cosmetics Supervision and Administration Regulations" to ensure product safety and quality[42]. - Increased competition in the cosmetics industry is anticipated as more companies enter the market, which may affect the company's market position and future performance[103]. Financial Management and Fundraising - The total amount of raised funds is RMB 416,556,000, with a net amount of RMB 373,045,189.65 after deducting issuance costs[86]. - The company has established special accounts for raised funds, ensuring proper management and oversight[87]. - The company has engaged in entrusted financial management, with a total of 20,801.28 million RMB in entrusted financial products, including 17,801.28 million RMB in bank financial products and 3,000 million RMB in brokerage financial products[94]. Shareholder and Governance - The company held one shareholders' meeting and five board meetings during the reporting period, ensuring effective governance and protection of shareholder rights[120]. - The company distributed cash dividends of RMB 4.1 per 10 shares to all shareholders, totaling RMB 41,328,000, which was completed on June 28, 2021[122]. - The company did not engage in any significant related party transactions during the reporting period[133]. Operational Efficiency - The company emphasizes strict quality control and efficient production capabilities to mitigate risks associated with demand fluctuations[103]. - The company integrates the development of cosmetic products and packaging, providing a one-stop service that reduces communication costs and improves supply efficiency[60]. - The company is focused on enhancing automation and efficiency to counteract rising labor costs[106].

Financial Performance - The company's revenue for Q1 2021 was ¥250,824,651.33, representing a 91.83% increase compared to ¥130,752,880.63 in the same period last year[8] - Net profit attributable to shareholders was ¥20,796,366.59, a significant increase of 270.56% from ¥5,612,096.08 in the previous year[8] - The net profit after deducting non-recurring gains and losses was ¥20,206,569.18, up 278.22% from ¥5,342,560.83 year-on-year[8] - Basic earnings per share were ¥0.28, reflecting a 300.00% increase from ¥0.07 in the previous year[8] - The company achieved operating revenue of CNY 250.82 million in Q1 2021, representing a 91.83% increase compared to CNY 130.75 million in Q1 2020[20] - Net profit attributable to shareholders reached CNY 20.80 million, a significant increase of 270.56% from the previous year's CNY 5.61 million[20] - The total comprehensive income for Q1 2021 was CNY 20,796,497.81, compared to CNY 5,632,305.07 in the prior year, marking an increase of about 269%[50] - The company's operating profit for the current period was CNY 24,815,724.64, compared to CNY 6,781,686.19 in the previous period, showing a significant improvement[49] Cash Flow and Liquidity - The net cash flow from operating activities reached ¥21,649,804.23, a remarkable increase of 1,846.98% compared to ¥1,111,970.49 in the same period last year[8] - Cash flow from operating activities was CNY 298,751,413.56, up from CNY 174,155,232.90 in the previous period, demonstrating strong cash generation capabilities[56] - Total cash inflow from financing activities reached CNY 401,029,798.00, compared to CNY 39,500,000.00 in the previous year, indicating a substantial increase of over 910%[58] - The total cash and cash equivalents at the end of Q1 2021 amounted to CNY 446,063,670.98, up from CNY 89,598,509.45 at the end of Q1 2020, marking an increase of approximately 397%[58] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,298,041,154.67, up 48.53% from ¥873,929,046.40 at the end of the previous year[8] - The total liabilities increased to CNY 373,640,553.32 from CNY 345,128,984.32, indicating a rise in financial obligations[41] - The company's total equity attributable to shareholders rose to CNY 924,400,601.35 from CNY 528,800,062.08, showing a substantial increase in shareholder value[41] - The company reported a significant inventory amount of 161.24 million yuan, representing 18.48% of current assets, which may lead to operational risks if not managed properly[25] Investment and R&D - Research and development expenses rose by 35.93% to CNY 4.80 million, reflecting increased investment in R&D activities[18] - The company is committed to continuous R&D investment to meet customer demands and maintain competitive advantages in technology and product updates[24] - The company absorbed investments amounting to CNY 385,029,798.00 during the quarter, with no comparable figure from the previous year[61] Risks and Challenges - The company faces risks from market demand fluctuations, with potential impacts on orders if macroeconomic conditions worsen, affecting consumer confidence and purchasing power[22] - High customer concentration poses a risk, as the top five customers account for 80.29% of revenue; any loss of market share by these customers could significantly impact business income[22] - The company is implementing measures to mitigate risks from raw material price fluctuations, particularly for key materials like PE and PP, which are influenced by international oil prices[22] Operational Efficiency - The company is actively enhancing its management mechanisms and human resources systems to adapt to rapid business expansion and improve overall management levels[24] - The company plans to leverage its OEM/ODM capabilities to expand its customer base and reduce reliance on a few major clients, thereby lowering customer concentration risks[23] - The company maintained its annual business plan without changes, progressing according to set goals in business development and project construction[21]

Financial Performance - The company's operating revenue for 2020 was ¥968.61 million, representing a 23.29% increase compared to ¥785.66 million in 2019[18]. - Net profit attributable to shareholders for 2020 was ¥93.41 million, a 47.51% increase from ¥63.33 million in 2019[18]. - The net profit after deducting non-recurring gains and losses was ¥90.74 million, up 45.71% from ¥62.28 million in 2019[18]. - The total assets at the end of 2020 reached ¥873.93 million, a 25.37% increase from ¥697.10 million at the end of 2019[18]. - The company's basic earnings per share for 2020 was ¥1.24, an increase of 47.62% compared to ¥0.84 in 2019[18]. - The weighted average return on equity for 2020 was 19.37%, an increase from 15.75% in 2019[18]. - The gross profit margin for the manufacturing sector was 25.26%, a decrease of 3.48% from the previous year[80]. - The company achieved a capacity utilization rate of 97% for cosmetics production, with a design capacity of 21,000 tons[74]. - The company reported a total revenue of 1.5 billion yuan for the fiscal year 2020, representing a year-over-year growth of 15%[138]. Cash Flow and Dividends - The company reported a cash dividend of 4.1 RMB per 10 shares (including tax) based on a total share capital of 10.08 million shares[5]. - The proposed cash dividend for 2020 is 4.1 CNY per 10 shares, totaling 41,328,000.00 CNY, which represents 44.24% of the net profit attributable to shareholders[134]. - The cash dividend payout ratio for 2020 is 44.24%, indicating a strong commitment to returning value to shareholders[134]. - The total cash dividend for 2020 is 41,328,000.00 CNY, with no other forms of cash distribution reported[134]. - Cash and cash equivalents decreased by 130.42% year-on-year, resulting in a net decrease of CNY 21,347,841.57[96]. Research and Development - The company invested 18.53 million yuan in R&D during the reporting period, focusing on formula optimization and production process improvements[69]. - The company has established a comprehensive service capability in R&D, formulation, filling, and plastic packaging design, enhancing its core competitiveness[58]. - The company holds 183 domestic patents and 1 foreign patent, including 32 invention patents, demonstrating its strong R&D capabilities[60]. - Research and development expenses amounted to ¥18,530,556.50, representing 1.91% of total revenue[93]. - The company plans to enhance R&D investment and technological innovation to improve product added value[143]. Market and Industry Trends - The average disposable income of Chinese residents increased from ¥20,167 in 2014 to ¥32,189 in 2020, contributing to a significant rise in consumer spending[45]. - The retail sales of cosmetics in China grew from ¥182.21 billion in 2014 to ¥297.34 billion in 2019, with a compound annual growth rate (CAGR) of 10.29%[45]. - In 2020, while the total retail sales of consumer goods in China decreased by 3.9%, the cosmetics sector still experienced a growth of 9.5%[45]. - The demand for OEM/ODM services in the cosmetics industry is increasing due to the need for rapid product development and market responsiveness[48]. - Increased competition in the cosmetics market is anticipated as more domestic and international brands enter, potentially affecting the company's market position[120]. Operational Strategies - The company operates under a direct sales model, optimizing production and sales based on customer demand[74]. - The company maintains a robust supplier evaluation system, ensuring a stable supply of raw materials and effective cost control[41]. - The company has established long-term relationships with suppliers, ensuring quality and stability in raw material procurement[41]. - The company is committed to continuous product development and innovation in response to market demands[43]. - The company aims to enhance its R&D capabilities by improving product formulations and production processes, focusing on skincare, haircare, and fragrance products[117]. Risk Management - The company emphasizes the potential risks including market demand fluctuations, high customer concentration, and raw material price volatility[5]. - The company faces risks from market demand fluctuations due to changes in consumer income and economic conditions, which could impact its business performance[120]. - The revenue from the top five customers accounted for 73.66% of total income, indicating a high customer concentration risk[121]. - The company is committed to improving its human resources system to enhance management competitiveness and attract talented individuals[119]. - The company has established a comprehensive quality management system to prevent potential product quality issues and associated legal risks[125]. Governance and Compliance - The company is committed to maintaining the accuracy and completeness of its financial reports, as stated by its management[4]. - The company has established a strong governance structure with all board members present for the report's approval[4]. - The company has committed to full, complete, and timely execution of its profit compensation measures[145]. - The company will actively promote compliance with regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange[145]. - The company has pledged to accept ongoing regulatory oversight regarding its compliance with these commitments[149]. Future Plans - The company plans to enhance R&D investment and improve management systems to strengthen core competitiveness and adapt to international market competition[121]. - The company aims to mitigate raw material price fluctuation risks by optimizing the supply chain and improving product quality to maintain profit margins[122]. - The company is actively pursuing business development plans to capitalize on growth opportunities in the cosmetics industry[126]. - The company plans to expand its production capacity to 38,000 tons of cosmetics and 30 million plastic packaging units annually after the completion of its new production base[117]. - The company expects a revenue growth of 10-15% for the upcoming fiscal year, driven by new product launches and market expansion strategies[139].